Key result
Prothrombin mutations associate with ~2-4x higher clot risk alongside acquired factors like cancer and COVID-19.
Why the study?
Thrombosis involves complex multifactorial, acquired, and hereditary mechanisms, warranting an overview of predisposing causes, risk factors, and therapeutic strategies.
This review summarizes the physiological mechanisms of hemostasis and the genetic and acquired factors predisposing individuals to arterial and venous thrombosis.
Answers are grounded in this paper and cite their sources.
Supports comprehensive thrombophilia workup in affected patients; leaves open underlying mechanisms in 40-60% of cases for ongoing research.[[1]](https://www.journalmeddbu.
Blood is a liquid tissue that is noncoagulated under physiological conditions. Hemostasis, on the other hand, is an important factor in maintaining fluidity, keeping the blood non-coagulated. Thrombosis is a condition that occurs as a result of an abnormal clot forming in the vein blocking blood flow. The causes of thrombosis are multifactorial. The involvement of many acquired and hereditary factors in the formation of thrombosis occurs through different mechanisms. Thrombus formation in the arterial and venous systems is thought to originate from different etiologies. Thrombophilia, on the other hand, describes the conditions in which the tendency to coagulate in the blood increases. In addition to hereditary causes, many diseases such as cancer and diabetes can increase the risk of thrombophilia. This compilation provides an overview of hemostasis and thrombosis, as well as determining the causes and risk factors of clotting by examining the mechanism of blood clot formation, describes the status of thrombosis studies within in vitro/in vivo studies observing thrombosis formation, therapeutic effects that may break the chain between antithrombotic therapy and bleeding risk, and provides discussions on effective drug delivery systems. This review provides a contemporary view of the most common inherited or acquired causes of thrombophilia and their role in the development of venous and arterial thrombosis.
No takes yet. Share an insight, caveat, or question.
Safgöl et al. (2023) conducted a review in Thrombosis. Genetic factors, such as the prothrombin G20210A mutation which increases clot risk by 2-4 times, and acquired factors like cancer and COVID-19 contribute to the multifactorial pathogenesis of thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: